DOLBY LABORATORIES, INC. DLB Balance Sheet

Dolby laboratories, inc. (DLB)

Balance Sheet / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Sep'09
ASSETS
Current assets:
Cash and cash equivalents
724	741	797	716	726	790	918	829	705	596	627	592	532	512	516	599	521	467	531	470	513	409	568	590	568	484	454	408	328	316	492	670	747	654	551	594	520	433	545	519	451
Restricted cash
9	11	8	7	8	8	7	7	8	7	7	6	5	5	3	5	5	4	2	1	2	2	2	3	3	3	3	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Short-term investments
174	170	119	120	158	175	178	195	240	252	247	247	194	164	121	118	104	139	138	165	188	211	231	181	169	179	140	109	124	118	302	322	350	367	391	309	266	270	302	303	283
Accounts receivable, net of allowance for doubtful accounts of $11,262 and $9,775
247	191	189	231	178	181	166	149	141	122	73	82	88	81	75	91	102	89	101	103	98	117	86	95	109	75	97	74	91	51	43	46	57	54	61	39	73	68	54	47	22
Contract assets
223	204	195	182	244	199	165	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Inventories, net
28	29	32	38	34	27	26	23	24	24	25	19	17	14	16	18	17	14	13	20	23	28	8	9	9	8	10	12	19	21	16	12	16	33	26	23	31	27	28	16	12
Deferred taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	87	80	86	86	85	82	81	84	79	84	82	80	89	94	92	90	91	94	97	102	101	83
Prepaid expenses and other current assets
51	52	39	41	44	39	34	32	35	31	30	29	32	32	26	37	36	23	32	45	34	37	22	22	24	25	28	30	29	28	33	27	26	26	36	36	35	25	26	23	45
Total current assets
1,459	1,401	1,381	1,338	1,395	1,423	1,496	1,238	1,154	1,035	1,011	978	871	811	759	871	786	737	821	895	942	892	1,005	986	967	858	818	714	677	618	970	1,169	1,294	1,229	1,158	1,093	1,022	924	1,060	1,012	900
Long-term investments
127	141	179	211	199	201	187	243	262	303	314	303	326	350	393	266	268	266	321	373	330	318	296	313	304	293	306	335	327	308	361	295	209	247	272	280	347	367	190	222	205
Property, plant, and equipment, net
551	549	537	524	537	523	514	502	500	493	485	476	471	459	443	428	416	410	403	386	358	330	289	252	242	243	242	245	249	254	254	140	135	123	117	108	103	99	94	95	92
Operating lease right-of-use assets
79	71	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Intangible assets, net
167	175	180	189	187	189	184	185	191	195	189	196	203	206	215	222	216	224	127	117	106	108	63	50	46	37	41	44	48	52	56	42	44	47	51	55	61	67	67	69	82
Goodwill
332	335	334	335	326	326	327	314	316	311	311	309	308	307	309	309	309	308	307	312	312	315	277	279	279	279	279	278	280	281	281	263	264	263	263	268	267	266	264	258	261
Deferred taxes
-	123	-	109	113	107	74	143	141	139	190	178	176	171	166	149	149	154	143	56	55	48	41	46	44	41	37	36	30	24	22	22	20	20	14	18	17	20	19	29	23
Other non-current assets
97	95	93	100	87	50	80	42	39	36	30	30	29	24	21	15	12	11	9	9	9	9	9	9	10	11	11	11	12	11	13	20	16	7	6	6	6	15	14	15	15
Deferred taxes
129	-	114	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total assets
2,944	2,893	2,821	2,809	2,846	2,823	2,865	2,669	2,606	2,514	2,533	2,473	2,387	2,330	2,310	2,263	2,158	2,113	2,133	2,151	2,114	2,022	1,984	1,938	1,896	1,765	1,737	1,667	1,626	1,551	1,960	1,953	1,985	1,939	1,884	1,831	1,825	1,760	1,711	1,703	1,581
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
9	13	15	14	14	9	21	16	18	14	14	12	10	11	17	14	17	12	20	27	14	9	15	11	10	7	10	8	6	9	14	12	5	9	10	5	7	11	3	13	12
Accrued liabilities
245	242	268	243	230	265	243	197	167	178	207	176	179	169	169	174	158	159	169	163	189	159	158	153	144	124	137	119	119	99	116	111	108	96	117	114	128	110	144	126	100
Income taxes payable
15	2	3	0	0	0	2	4	4	6	1	0	0	1	2	0	0	2	0	0	1	1	2	7	9	2	3	1	5	12	2	3	9	18	4	3	0	14	7	17	3
Contract liabilities
19	19	19	19	20	19	17	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating lease liabilities
17	15	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Current portion of long-term debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1
Deferred revenue
-	-	-	-	-	-	-	21	22	23	23	22	23	24	24	22	22	21	18	18	16	21	12	13	12	15	20	23	20	22	23	25	26	24	26	12	10	8	9	12	37
Total current liabilities
307	293	306	278	265	294	285	240	213	223	245	213	213	207	213	212	198	196	209	209	221	192	189	185	176	150	172	152	152	144	156	152	149	149	159	136	147	144	165	171	156
Non-current contract liabilities
25	23	24	24	24	23	25	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-current operating lease liabilities
64	57	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Long-term debt, net of current portion
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4	5
Long-term deferred revenue
-	-	-	-	-	-	-	37	37	36	36	36	35	34	35	34	35	33	30	29	29	23	19	19	20	19	19	19	19	18	18	16	16	17	15	14	13	13	12	11	10
Deferred taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	2	2	2	0	0	0	0	0	0	0	11	12	13
Other non-current liabilities
178	179	177	186	204	156	183	203	202	198	107	101	95	88	82	76	70	71	77	72	64	55	43	47	46	46	45	46	43	40	39	32	31	27	23	23	23	29	27	29	31
Total liabilities
575	554	508	489	494	474	494	481	452	458	389	350	344	330	331	323	304	301	317	311	315	271	252	252	243	215	237	217	217	206	217	202	198	195	199	175	185	188	217	230	218
Stockholders’ equity:
Additional paid-in capital
-	-	-	0	0	0	66	89	113	72	61	51	37	36	42	15	0	0	17	65	50	45	46	41	49	23	18	17	3	0	0	64	149	196	210	255	303	320	329	375	478
Retained earnings
2,395	2,351	2,327	2,328	2,361	2,361	2,313	2,105	2,039	1,985	2,083	2,075	2,013	1,977	1,938	1,926	1,853	1,816	1,800	1,764	1,739	1,691	1,660	1,614	1,574	1,498	1,454	1,408	1,378	1,316	1,709	1,657	1,606	1,518	1,445	1,366	1,304	1,222	1,135	1,070	852
Accumulated other comprehensive (loss)
-31	-18	-20	-14	-14	-18	-15	-13	-5	-8	-7	-11	-14	-19	-10	-10	-8	-12	-11	-7	-7	-2	3	8	8	7	7	5	8	11	10	5	9	7	7	11	10	8	7	4	9
Total stockholders’ equity – Dolby Laboratories, Inc.
2,364	2,333	2,307	2,314	2,347	2,343	2,363	2,181	2,147	2,049	2,136	2,115	2,036	1,994	1,970	1,931	1,845	1,803	1,807	1,822	1,782	1,735	1,710	1,664	1,632	1,529	1,481	1,431	1,390	1,327	1,720	1,728	1,764	1,722	1,663	1,633	1,618	1,550	1,473	1,450	1,341
Controlling interest
5	5	5	5	5	5	6	6	6	6	7	6	6	6	8	8	8	8	8	17	16	16	21	21	20	19	18	18	17	18	22	22	22	21	21	22	21	21	20	22	21
Total stockholders’ equity
2,369	2,338	2,313	2,320	2,352	2,348	2,370	2,187	2,153	2,055	2,143	2,122	2,043	2,000	1,978	1,940	1,854	1,812	1,816	1,839	1,799	1,751	1,731	1,686	1,653	1,549	1,500	1,449	1,408	1,345	1,743	1,751	1,787	1,744	1,685	1,655	1,640	1,571	1,494	1,473	1,363
Total liabilities and stockholders’ equity
2,944	2,893	2,821	2,809	2,846	2,823	2,865	2,669	2,606	2,514	2,533	2,473	2,387	2,330	2,310	2,263	2,158	2,113	2,133	2,151	2,114	2,022	1,984	1,938	1,896	1,765	1,737	1,667	1,626	1,551	1,960	1,953	1,985	1,939	1,884	1,831	1,825	1,760	1,711	1,703	1,581
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 64,422,131 shares issued and outstanding at March 27, 2020 and 63,911,270 at September 27, 2019
Common stock
0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 36,224,820 shares issued and outstanding at March 27, 2020 and 36,229,820 at September 27, 2019
Common stock
0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-